This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|November 2, 2013
- Pharmaceutical Technology-11-02-2013
- Volume 37
- Issue 11
Pharmaceutical Technology, November 2013 Issue (PDF)
Click the title above to open the Pharmaceutical Technology November 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 13 years ago
Report from Brazil November 2013almost 13 years ago
Applying Catalysis to Optimize API Synthesisalmost 13 years ago
Predicting Long-Term Storage Stability of Therapeutic Proteinsalmost 13 years ago
Control of Elemental Impuritiesalmost 13 years ago
Automation System Improves Operational Insightalmost 13 years ago
Disposable Applications in Demand by Biopharmaalmost 13 years ago
Solvent-Free Coating of Traditional and User-Friendly Dosage Formsalmost 13 years ago
Congress Revises Rules for Drug Compounding and Supply-Chain Securityalmost 13 years ago
Can Pharma Defy Gravity at the Patent Cliff?almost 13 years ago
Defining and Presenting Overkill Cycle ValidationAdvertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement